Literature DB >> 10211149

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study.

T Hope1, J Keene, C G Fairburn, R Jacoby, R McShane.   

Abstract

BACKGROUND: Alzheimer's disease and other types of dementia are characterised by numerous psychiatric and behavioural changes. Little is known of their natural history. AIMS: To investigate the sequence and pattern of these changes throughout the course of dementia.
METHOD: One hundred people, initially living at home with carers, entered a prospective, longitudinal study. At four-monthly intervals, behavioural and psychiatric symptoms were assessed using the Present Behavioural Examination and Mini-Mental State Examination. Follow-up continued for up to nine years (mean 3.3 years; s.d. 2.4). Patterns of onset and disappearance of these symptoms, their sequence and association with time of death and cognitive decline were analysed. Autopsy confirmed a diagnosis of pure Alzheimer's disease in 48 subjects. Data for this subgroup are presented.
RESULTS: Some changes tend to occur earlier than others but changes can occur at almost any time in the course of dementia.
CONCLUSIONS: The natural history of behaviour changes in Alzheimer's disease shows great individual variation although some changes tend to follow a recognisable sequence.

Entities:  

Mesh:

Year:  1999        PMID: 10211149     DOI: 10.1192/bjp.174.1.39

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  27 in total

Review 1.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Alzheimer's disease: the strength of association of costs with different measures of disease severity.

Authors:  J Mauskopf; J Racketa; E Sherrill
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

3.  Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.

Authors:  G Livingston; A E Walker; C L E Katona; C Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-26       Impact factor: 10.154

4.  Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Authors:  Pierre N Tariot; Lon S Schneider; Jeffrey Cummings; Ronald G Thomas; Rema Raman; Laura J Jakimovich; Rebekah Loy; Barbara Bartocci; Adam Fleisher; M Saleem Ismail; Anton Porsteinsson; Michael Weiner; Clifford R Jack; Leon Thal; Paul S Aisen
Journal:  Arch Gen Psychiatry       Date:  2011-08

5.  Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

Authors:  Mitchell K P Lai; Shirley W Tsang; Margaret M Esiri; Paul T Francis; Peter T-H Wong; Christopher P Chen
Journal:  Psychopharmacology (Berl)       Date:  2010-07-13       Impact factor: 4.530

6.  The symptom experience of community-dwelling persons with dementia: self and caregiver report and comparison with standardized symptom assessment measures.

Authors:  Teresa M Murray; Greg A Sachs; Carol Stocking; Joseph W Shega
Journal:  Am J Geriatr Psychiatry       Date:  2012-04       Impact factor: 4.105

Review 7.  Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.

Authors:  H M Lamb; K L Goa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Electrocardiographic monitoring for new prescriptions of quetiapine co-prescribed with acetylcholinesterase inhibitors or memantine from 2005 to 2009. A population study on community-dwelling older people in Italy.

Authors:  Claudio Bilotta; Carlotta Franchi; Alessandro Nobili; Paola Nicolini; Codjo Djignefa Djade; Mauro Tettamanti; Luca Pasina; Ida Fortino; Angela Bortolotti; Luca Merlino; Carlo Vergani
Journal:  Eur J Clin Pharmacol       Date:  2014-09-20       Impact factor: 2.953

Review 9.  Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events.

Authors:  Marianne B van Iersel; Sytse U Zuidema; Raymond T C M Koopmans; Frans R J Verhey; Marcel G M Olde Rikkert
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 10.  Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease.

Authors:  Greg L Plosker; Katherine A Lyseng-Williamson
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.